Abiopharma

🔍 Heminger Gary R. (Director)

Company: PPG INDUSTRIES INC (PPG)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Sold 1,849 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Acquired 1,849 shares of Phantom Stock Units (Derivative)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 12,749.94 | transaction_form_type: 4 | Footnotes: F2, F3, F3, F4
• Acquired 1,684 shares of Restricted Stock Units (Derivative)
  Date: 2026-04-16 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,684.00 | transaction_form_type: 4 | Footnotes: F5, F6, F6

Footnotes:

• F1: Upon the vesting of restricted stock units on April 15, 2026, which were granted to the reporting person on April 17, 2025, the reporting person deferred the receipt of 1,849 shares of common stock and received instead shares of phantom stock pursuant to the PPG Industries, Inc. Deferred Compensation Plan for Directors. As a result, the reporting person is reporting the conversion of restricted stock units relating to 1,849 shares of common stock in exchange for shares in phantom stock.
• F2: The security converts to common stock on a one-for-one basis.
• F3: After termination of service as a Director of PPG Industries, Inc.
• F4: Total of all phantom stock units held by the reporting person in the PPG Industries, Inc. Deferred Compensation Plan for Directors. Phantom stock units represent interests in an unfunded unitized company stock fund comprised of stock and cash. The number of shares attributed to the reporting person as a Plan participant may change from time to time without the volition of the reporting person depending on the fair market value of the issuer common stock and the amount of cash in the fund.
• F5: Each restricted stock unit represents a contingent right to receive one share of PPG common stock.
• F6: The restricted stock units vest on April 14, 2027.